JBIO
Jade Biosciences
JBIO
JBIO
68 hedge funds and large institutions have $803M invested in Jade Biosciences in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.03% more ownership
Funds ownership: 3.15% → 3.18% (+0.03%)
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
Holders
68
Holding in Top 10
8
Calls
–
Puts
–
Top Buyers
| 1 | +$18.2M | |
| 2 | +$11.1M | |
| 3 | +$6.36M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.13M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$3.57M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$9.1M | |
| 3 | -$4.58M | |
| 4 |
BlackRock
New York
|
-$3.15M |
| 5 |
VA
VR Adviser
New York
|
-$2.52M |